Tuesday, August 08, 2023 8:05:35 AM
Reports Record Q2 '23 Financial & Operating Results
👉Q2 '23 revenue of $17.6m, an increase of 8% over the Q2 '22
👉U.S. treatment session revenue increased 9% over the Q2 of '22
👉Shipped 54 NeuroStar systems
Recent STIM News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/13/2025 01:04:32 PM
- Neuronetics Provides Business Update and Issues 2025 Guidance • GlobeNewswire Inc. • 01/13/2025 01:00:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2024 10:54:25 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2024 10:00:04 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2024 10:00:04 PM
- Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 12/18/2024 09:30:00 PM
- Form SC 13D - General Statement of Acquisition of Beneficial Ownership • Edgar (US Regulatory) • 12/18/2024 02:15:11 AM
- Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 12/16/2024 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/12/2024 10:00:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/12/2024 10:00:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/12/2024 10:00:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/10/2024 09:45:53 PM
- Neuronetics and Greenbrook TMS Announce Closing of Transaction • GlobeNewswire Inc. • 12/10/2024 03:00:48 PM
- Neuronetics to Present at the Piper Sandler 36th Annual Healthcare Conference • GlobeNewswire Inc. • 11/20/2024 01:30:00 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2024 04:17:47 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/13/2024 11:44:28 AM
- CORRECTION—Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results • GlobeNewswire Inc. • 11/12/2024 11:45:48 PM
- Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 11/12/2024 09:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2024 12:31:12 PM
- Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results • GlobeNewswire Inc. • 11/12/2024 12:10:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2024 12:03:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2024 12:01:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2024 12:01:07 PM
UAV Corp Skyborne Technology Secures $105M in Sales Contract LOIs for Revolutionary DART Series Airships • UMAV • Jan 13, 2025 11:00 AM
SANUWAVE Health Announces Preliminary Revenue Results for the Fourth Quarter 2024 (Ended December 31, 2024) • SNWV • Jan 13, 2025 8:10 AM
SANUWAVE Health Appoints Industry Veteran Timothy Wern as Executive Vice President of Sales • SNWV • Jan 13, 2025 8:08 AM
North Bay Resources Announces Operation of New Gravity Circuit at Bishop Gold Mill, California • NBRI • Jan 10, 2025 8:29 AM
Cannabix Technologies Announces Key Hardware Advancements to Marijuana Breathalyzer Technology • BLO • Jan 9, 2025 8:49 AM
UAV Corp. (UMAV) Further Reduces Authorized Shares to 500 Million • UMAV • Jan 8, 2025 2:27 PM